Field Assessment of the Level of Protection Conferred by a Newly Prepared Combined Inactivated Vaccine against E. coli and P. multocida in Rabbit in Egypt
Pasteurellosis is the most prevalent, extremely contagious bacterial disease among domestic rabbits and is considered the leading cause of deaths in rabbits, resulting in enormous economic losses to the rabbit industry. Screening for bacterial agents causing mortalities in rabbits revealed the presence of Enterobacteriacae species in approximately 42% of studied cases, with E. coli the most commonly isolated organism. The present study was designed to evaluate the immune response of rabbits vaccinated with a locally prepared, combined inactivated vaccine of Pasteurella multocida and E. coli, adjuvanated with Montanide ISA70. A total of 370 rabbits, aged 2 - 3 weeks, were divided into four groups: (G1) vaccinated with a polyvalent P. multocida vaccine, (G2) vaccinated with a polyvalent E. coli vaccine, (G3) vaccinated with a combined inactivated Montanide ISA70 vaccine of P. multocida and E. coli, and (G4) kept as a non-vaccinated control group. All rabbits received two doses of 0.5 ml of the prepared vaccines, administered one month apart, and were then challenged with virulent strains of P. multocida and E. coli three weeks after the second vaccination. The prepared vaccines were evaluated by determining humoral immunity using indirect haemagglutination (IHA) test and ELISA. The potency of the vaccines was assessed through challenge and determination of LD50. Experimental findings on the prepared polyvalent combined inactivated P. multocida and E. coli vaccine indicated that it is a potent vaccine, producing the highest antibody titers and a 90% protection rate against challenges with virulent strains of P. multocida type A, D2, and E. coli types O157, O151 and O125. Thus, this vaccine is promising in addressing both P. multocida and E. coli problems in rabbits, farms, providing significant protection, and we recommend its commercial production to help rabbit producers control these two major bacterial infections.
References
[1]
Mukaila, R. (2022) Agricutural Entrepreneurship among the Youth: The Case of Youth Involvement in Rabbit Production in Nigeria. International Entrepreneurship Review, 8, 35-46. https://doi.org/10.15678/ier.2022.0801.03
[2]
Da Silva, K.G., Borges, T.D., Costa, L.B. and Sotomaior, C.S. (2021) Characteristics of Meat, Pet, and Research Rabbit Farms in Brazil: An Overview Based on Twelve Farms. World Rabbit Science, 29, 115-123. https://doi.org/10.4995/wrs.2021.14125
[3]
Abd El-Ghany, W.A. (2023) Pasteurellosis: A Significant Bacterial Disease in Rabbit Production. Veterinarskastanica, 54, 569-580. https://doi.org/10.46419/vs.54.5.1
[4]
Sharma, A., Sharma, S. and Singh, A.K. (2022) Pasteurellosis in Rabbits. Acta Scientific Veterinary Sciences, 4, 185-187. https://doi.org/10.31080/asvs.2022.04.0485
[5]
Wilson, B.A. and Ho, M. (2013) Pasteurella Multocida: From Zoonosis to Cellular Microbiology. Clinical Microbiology Reviews, 26, 631-655. https://doi.org/10.1128/cmr.00024-13
[6]
Ismail, A.K., Abdien, H.M.F., Hamed, D.M. and El Feil, W.M.K. (2017) Prevalence of Some Enteric Bacterial Infections Causing Rabbit Enteritis and Attempts to Control Rabbit Coli Enteritis with Phytobiotics. Zagazig Veterinary Journal, 45, 91-101. https://doi.org/10.21608/zvjz.2017.29244
[7]
Aboelhadid, S.M., Hashem, S.A., Abdel-Kafy, E.M., Abdel-Baki, A.S., Al-Quraishy, S., Abed, A.H., et al. (2022) Prevalence and Antimicrobial Sensitivity of Escherichia Coli and Salmonella Species in Field Cases of Rabbit Intestinal Coccidiosis Treated with Prebiotic. Austral Journal of Veterinary Sciences, 54, 9-16. https://doi.org/10.4067/s0719-81322022000100009
[8]
Alshimaa, A.M. (2007) Bacteriological Studies on Enteric in Rabbits. Master’s Thesis. Beni-Suef University.
[9]
Tarr, P.I., Gordon, C.A. and Chandler, W.L. (2005) Shiga-Toxin-Producing Escherichia Coli and Haemolytic Uraemic Syndrome. The Lancet, 365, 1073-1086. https://doi.org/10.1016/s0140-6736(05)71144-2
[10]
Ruzauskas, M. (2005) Development and Assay of Inactivated Pasteurella Vaccine for Rabbits. BIOLOGIJA, 51, 35-39.
[11]
El-Jakee, J.K., Moussa, I.M., Omran, M.S., Ahmed, B.M., Elgamal, M.A., Hemeg, H.A., et al. (2020) A Novel Bivalent Pasteurellosis-RHD Vaccine Candidate Adjuvanted with Montanide ISA70 Protects Rabbits from Lethal Challenge. Saudi Journal of Biological Sciences, 27, 996-1001. https://doi.org/10.1016/j.sjbs.2019.12.042
[12]
WOAH (2023) CHAPTER 3.4.10. Haemorrhagic sepyicaemia (Pasteurella multocida) Serotype 6: B and 5: E.
[13]
Code of Federal Regulations (CFR) (2019) Title 9: Animals and Animal Products Part 53-Foot-and-Mouth Disease, Pleuropneumonia, and Certain Other Communicable Diseases of Livestock or Poultry.
[14]
Reed, L.J. and Muench, H. (1938) Simple Method of Estimating 50 Percent end Point. The American Journal of Tropical Medicine and Hygiene, 27, 793-799.
[15]
Farrukh Im, R., Hussain Na, Z., Mahmood Ch, T. and Shauket, M. (2000) Studies on Pasteurella Multocida: Indirect Haemagglutination Test for the Identification of Serological Types. Pakistan Journal of Biological Sciences, 3, 503-504. https://doi.org/10.3923/pjbs.2000.503.504
[16]
Barrow, P.A. (1992) Elisas and the Serological Analysis of Salmonella Infections in Poultry: A Review. Epidemiology and Infection, 109, 361-369. https://doi.org/10.1017/s0950268800050354
[17]
Eid, A.M. and Ibraheem, O.K. (2006) Sudden Death among Rabbits in Sharkia Prov-ince. Zagazig Veterinary Journal, 34, 108-119.
[18]
Soliman, M., Rhaman, M., Samy, M., Mehana, O. and Nasef, S. (2016) Molecular, Clinical and Pathological Studies on Viral Rabbit Hemorrhagic Disease. Alexandria Journal of Veterinary Sciences, 48, 20-26.
[19]
Harper, M., John, M., Edmunds, M., Wright, A., Ford, M., Turni, C., et al. (2016) Protective Efficacy Afforded by Live Pasteurella Multocida Vaccines in Chickens Is Independent of Lipopolysaccharide Outer Core Structure. Vaccine, 34, 1696-1703. https://doi.org/10.1016/j.vaccine.2016.02.017
[20]
Egyptian Standards for Evaluation of Veterinary Biologics (2004) Central Laboratory for Evaluation of Veterinary Biologics, Ministry of Agriculture and Land Reclamation, Agricultural Research Center, 161-164.
[21]
El-Sayed, E.I., Fatma, M.G. and Eman, M.S. (2020) The Use of Single Dose Dependent Evaluation of Rabbit Pasteurellosis Vaccines in Comparison with Booster Dose Evaluation Assay in Mice. EC Veterinary Science, 5, 76-83.
[22]
Youssef, E.A. and Tawfik, H.E. (2011) Improvement of Rabbit Pasteurellosis Vaccine Using Montanide ISA50. Egyptian Journal of Agricultural Research, 89, 697-708. https://doi.org/10.21608/ejar.2011.176060
[23]
Jaffri, K.T., Gill, Z.J., Bhatti, A.R. and Raza, A. (2006) Immune Response of Buffalo Calves to Haemorrhagic Septicemia Oil Adjuvant and Alum Precipitated Vaccine. International Journal of Agriculture and Biology, 8, 645-647.
[24]
Amal, I., Daoud, A. and El-Bourdiny, F. (2005) Preparation of Inactivated Infectious Bronchitis Virus Disease Vaccine Using New Oil Adjuvant Private. Veterinary Medical Journal (Giza), 53, 329-339. https://doi.org/10.21608/vmjg.2005.384705
[25]
Komori, T., Saito, K., Sawa, N., Shibasaki, Y., Kohchi, C., Soma, G. and Inagawa, H. (2015) Innate Immunity Activated by Oral Administration of LPSp Is Phylogenetically Preserved and Developed in Broiler Chickens. Anticancer Research, 35, 4461-4466.
[26]
Shimizu, M., Fitzsimmons, R.C. and Nakai, S. (1988) Anti-E. coli Lmmunoglobulin Y Isolated from Egg Yolk of Immunized Chickens as a Potential Food Ingredient. Journal of Food Science, 53, 1360-1368. https://doi.org/10.1111/j.1365-2621.1988.tb09277.x
